Open Philanthropy recommended an investment of $500,000 in Drizzle Health to support the development of MagnaSlide, a tuberculosis (TB) diagnostic tool. Diagnosis is a significant bottleneck to treating TB, and MagnaSlide improves the performance of smear microscopy (the most common diagnostic test in low- and middle-income countries).
This falls within our focus area of global health R&D.